Avanti Polar Lipids: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
'''Avanti Polar Lipids, Inc.''' is a company that develops, manufactures, markets and distributes compounds used in pharmaceutical research and drug delivery. It was founded in [[1969]] by [[Walt Shaw]] and is located at 700 [[Industrial Park Drive]] in [[Alabaster]]. The company's best-known achievement is the development of "Exosurf", a surfactant used in the treatment of infant respiratory distress syndrome, common in premature births. | '''Avanti Polar Lipids, Inc.''' is a company that develops, manufactures, markets and distributes compounds used in pharmaceutical research and drug delivery. It was founded in [[1969]] by [[Walt Shaw]] and is located at 700 [[Industrial Park Drive]] in [[Alabaster]]. The company's best-known achievement is the development of "Exosurf", a surfactant used in the treatment of infant respiratory distress syndrome, common in premature births. | ||
The company constructed a new 14,000 square-foot office for its analytical services division in [[2011]]. | The company constructed a new 14,000 square-foot office for its analytical services division in [[2011]]. In [[2020]] Avanti was acquired by Croda International of Snaith, United Kingdom. | ||
{{stub}} | {{stub}} | ||
==References== | ==References== | ||
* Bradford, Nicole (May 18, 2012) "Magic City biotech: Snapshot of microscopic discoveries with big market potential." {{BBJ}} | * Bradford, Nicole (May 18, 2012) "Magic City biotech: Snapshot of microscopic discoveries with big market potential." {{BBJ}} | ||
* Patchen, Tyler (July 9, 2020) "European company acquires local biotech firm." {{BBJ}} | |||
==External links== | ==External links== | ||
Revision as of 17:09, 9 July 2020
Avanti Polar Lipids, Inc. is a company that develops, manufactures, markets and distributes compounds used in pharmaceutical research and drug delivery. It was founded in 1969 by Walt Shaw and is located at 700 Industrial Park Drive in Alabaster. The company's best-known achievement is the development of "Exosurf", a surfactant used in the treatment of infant respiratory distress syndrome, common in premature births.
The company constructed a new 14,000 square-foot office for its analytical services division in 2011. In 2020 Avanti was acquired by Croda International of Snaith, United Kingdom.
References
- Bradford, Nicole (May 18, 2012) "Magic City biotech: Snapshot of microscopic discoveries with big market potential." Birmingham Business Journal
- Patchen, Tyler (July 9, 2020) "European company acquires local biotech firm." Birmingham Business Journal
External links
- Avanti Polar Lipids website